Skip to main content

Editorial: Why do We Choose to Address Health 2020?

References

  1. 1.

    Tetlock PE. Expert Political Judgment: How Good Is It? How Can We Know? Princeton, NJ: Princeton University Press; 2005.

    Google Scholar 

  2. 2.

    Taleb NN. The Black Swan: The Impact of the Highly Improbable. New York, NY: Random House; 2nd edition, 2010.

    Google Scholar 

  3. 3.

    Drucker P. On the Profession of Management. Boston, MA: Harvard Business School Press; 2003.

    Google Scholar 

  4. 4.

    Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, et al. Stenting versus aggressive medical thearapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

    Article  PubMed Central  Google Scholar 

  8. 8.

    Nilsen A, LaCrue AN, White KL, Forquer IP, Cross RM, et al. Quinolone-3-diarylethers: a new class of antimalarial drug. Sci Trans Med. 2013;5:177ra37.

    Article  Google Scholar 

  9. 9.

    Sáez-Cirión A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 2013;9:e1003211.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Cami A, Arnold A, Manzi S, Reis B. Predicting adverse drug events using pharmacological network models. Sci Transl Med. 2011;3:114ra127.

    Article  PubMed  Google Scholar 

  11. 11.

    Tucker A. Jack Andraka, the teen prodigy of pancratic cancer. Smithsonian. December 2012. Available from URL: http://www.smithsonianmag.com/science-nature/Jack-Andraka-the-Teen-Prodigy-of-Pancreatic-Cancer-179996151.html (Accessed 25 July 2013).

    Google Scholar 

  12. 12.

    Donabedian A. An Introduction to Quality Assurance in Health Care. New York, NY; Oxford University Press: 2002.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Antoine Flahault MD, PhD.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Flahault, A., Martin-Moreno, J.M. Editorial: Why do We Choose to Address Health 2020?. Public Health Rev 35, 1 (2013). https://doi.org/10.1007/BF03391686

Download citation